All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

A 45-year-old man is brought to the emergency department by his spouse due to acute-onset confusion, agitation, and profound diaphoresis. His medical history includes major depressive disorder, for which he has taken citalopram for three years, and gastroesophageal reflux disease, managed with daily omeprazole. Ten days ago, he was discharged from the hospital after receiving treatment for a complicated methicillin-resistant *Staphylococcus aureus* (MRSA) cellulitis; he is currently completing a 14-day oral course of linezolid. Over the past 48 hours, he developed severe nausea and began taking ondansetron, which he had left over from a prior prescription. He also reports taking several doses of ibuprofen for a mild headache. On physical examination, his temperature is 39.1°C (102.4°F), blood pressure is 168/96 mm Hg, and pulse is 122/min. Neurologic examination reveals spontaneous ocular clonus, generalized hyperreflexia, and inducible ankle clonus that is most pronounced in the lower extremities. Which of the following agents from this patient's pharmacological history synergistically interact to precipitate his current toxidrome? (Select all that apply)

Select all that apply

Citalopram

Linezolid

Ondansetron

Omeprazole

Ibuprofen

Show answer & explanation

Answer: Citalopram; Linezolid; Ondansetron

Answer

The medications that synergistically interact to precipitate this patient's serotonin syndrome are citalopram, linezolid, and ondansetron.

The patient's clinical presentation of hyperthermia, autonomic instability, altered mental status, and prominent clonus is characteristic of serotonin syndrome. This toxidrome is caused by excessive serotonergic activity in the central and peripheral nervous systems, typically resulting from the concurrent use of multiple serotonergic medications. In this patient's history, citalopram (an SSRI), linezolid (an oxazolidinone antibiotic with non-selective MAOI properties), and ondansetron (a 5-HT3 receptor antagonist) all directly increase serotonergic tone. Their combined use precipitated the severe toxidrome.

Step-by-Step Solution

Evaluate the patient's acute physical examination findings.

The patient exhibits hyperthermia, autonomic instability, altered mental status, and distinct neuromuscular hyperactivity characterized by spontaneous ocular and inducible ankle clonus.

To establish a primary syndromic diagnosis, which in this case is highly consistent with serotonin syndrome.

Review the patient's chronic medication history.

The patient has been on maintenance therapy with citalopram, a selective serotonin reuptake inhibitor (SSRI), for three years.

SSRIs form the foundational risk factor for serotonin toxicity, but typically require the addition of interacting agents to precipitate a life-threatening crisis.

Analyze recently added medications for serotonergic or interacting properties.

Linezolid is identified as possessing weak MAOI activity, and ondansetron is identified as a serotonergic 5-HT3 receptor antagonist.

To determine the exact precipitants; the combination of an SSRI with an MAOI (linezolid) and a 5-HT3 antagonist (ondansetron) causes profound serotonin accumulation, directly explaining the toxidrome.

Key Concept

Serotonin syndrome is a life-threatening toxidrome precipitated by the concurrent use of multiple serotonergic medications. A thorough medical history evaluation must identify 'hidden' serotonergic agents, such as the antibiotic linezolid (which has MAOI activity) and antiemetics like ondansetron, especially in patients already taking baseline SSRIs.

Question 1502Question →

A primary care physician evaluates a female patient who reports 14 months of progressively worsening deep pain in her ribs and lower extremities. The patient, a 42-year-old architect, also describes profound proximal muscle weakness, noting that she now requires the use of her arms to stand up from a seated position. She has no significant past medical history and takes no medications. Vital signs are within normal limits. Physical examination reveals tenderness to palpation over the anterior ribs bilaterally and 4/5 strength in the proximal hip flexors.

Laboratory studies reveal the following:

Test	Result	Reference Range
Serum calcium	9.1 mg/dL	8.4-10.2 mg/dL
Serum phosphorus	1.3 mg/dL	2.7-4.5 mg/dL
Alkaline phosphatase	285 U/L	40-120 U/L
Parathyroid hormone, intact	35 pg/mL	10-65 pg/mL
25-hydroxyvitamin D	42 ng/mL	20-50 ng/mL
1,25-dihydroxyvitamin D	9 pg/mL	18-72 pg/mL
Serum creatinine	0.8 mg/dL	0.6-1.1 mg/dL

Further evaluation shows a fractional excretion of phosphorus of 28% (normal in the setting of hypophosphatemia: <5%). Radiographs of the pelvis demonstrate symmetric, thin, radiolucent lines perpendicular to the cortex of the femoral necks.

Which of the following best describes the underlying paraneoplastic mechanism responsible for this patient's condition, and the most appropriate next step in management to confirm the etiology?

Secretion of a peptide that downregulates proximal tubule sodium-phosphate cotransporters; order a Gallium-68 DOTATATE positron emission tomography scan

Secretion of a protein with structural homology to parathyroid hormone; order a technetium-99m sestamibi scintigraphy scan

Release of local cytokines that stimulate massive osteoclast-mediated bone resorption; order a serum free light chain assay and bone marrow biopsy

Somatic mutations leading to disorganized, hyperactive osteoblast and osteoclast activity; order a technetium-99m skeletal bone scan

Tumor-mediated upregulation of osteoclast activity from an occult primary carcinoma; administer intravenous zoledronic acid

Show answer & explanation

Answer: Secretion of a peptide that downregulates proximal tubule sodium-phosphate cotransporters; order a Gallium-68 DOTATATE positron emission tomography scan

Answer

The correct mechanism is the ectopic secretion of a peptide (FGF23) that downregulates proximal tubule sodium-phosphate cotransporters, and the most appropriate next step is to order a Gallium-68 DOTATATE positron emission tomography scan.

The correct answer accurately describes the pathophysiology and clinical management of Tumor-Induced Osteomalacia (TIO). The patient's presentation of proximal muscle weakness, bone pain, and pseudofractures (Looser zones) combined with severe hypophosphatemia, high fractional excretion of phosphorus, and normal calcium is pathognomonic. This syndrome is caused by small, typically benign phosphaturic mesenchymal tumors that autonomously secrete fibroblast growth factor 23 (FGF23). FGF23 is a phosphatonin that acts on the renal proximal tubule to downregulate sodium-phosphate cotransporters (NaPi-IIa and NaPi-IIc), causing massive phosphaturia. Concurrently, FGF23 inhibits 1-alpha-hydroxylase, resulting in an inappropriately low level of 1,25-dihydroxyvitamin D (despite normal precursor stores), distinguishing this from primary hyperparathyroidism where 1,25-dihydroxyvitamin D is elevated. Because these mesenchymal tumors are frequently tiny, ubiquitous, and express somatostatin receptors (SSTRs), functional imaging with a Gallium-68 DOTATATE PET/CT scan is the preferred next step to localize the tumor for curative surgical resection.

Step-by-Step Solution

Analyze the metabolic panel and vitamin D indices.

The patient has severe hypophosphatemia with inappropriate renal phosphate wasting (FEPO4 28%), elevated alkaline phosphatase, and low active vitamin D (1,25-OH), despite normal 25-OH vitamin D, calcium, and intact PTH.

To narrow the differential diagnosis of diffuse bone pain and objectively identify the specific mineral metabolism defect.

Correlate the laboratory findings with the radiographic presentation.

The presence of symmetric radiolucent lines perpendicular to the cortex (Looser zones or pseudofractures) confirms osteomalacia secondary to chronic hypophosphatemia.

To distinguish defective bone mineralization from other structural causes of bone pain, such as lytic metastases or Paget disease.

Identify the exact pathophysiologic mediator responsible for the lab pattern.

The combination of renal phosphate wasting and suppressed 1-alpha-hydroxylase activity in the setting of normal PTH uniquely points to excess fibroblast growth factor 23 (FGF23).

FGF23 is a phosphatonin that acts specifically on the proximal tubule to inhibit both sodium-phosphate cotransporters and 1-alpha-hydroxylase.

Determine the diagnostic test of choice to identify the paraneoplastic source.

Select Gallium-68 DOTATATE PET imaging to locate an occult phosphaturic mesenchymal tumor.

These tumors cause Tumor-Induced Osteomalacia (TIO) and characteristically express high levels of somatostatin receptors, making functional SSTR-imaging the gold standard for localization.

Key Concept

Tumor-induced osteomalacia (TIO) mediated by ectopic FGF23 secretion from phosphaturic mesenchymal tumors.

Estimated Time:2m 0s

Question 1503Question →

A 38-year-old man comes to the transplant clinic for urgent evaluation due to a 2-day history of decreased urine output, fatigue, and low-grade fever. He underwent a deceased-donor renal transplantation 6 weeks ago for end-stage renal disease secondary to IgA nephropathy. His current medications include tacrolimus, mycophenolate mofetil, and prednisone. Temperature is 37.8°C (100.0°F), blood pressure is 155/95 mmHg, and pulse is 92/min. Physical examination reveals tenderness over the allograft in the right lower quadrant. Laboratory studies show a serum creatinine of 2.9 mg/dL, increased from a baseline of 1.3 mg/dL one week ago. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the management of this patient's suspected acute rejection.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing suspected acute transplant rejection is to first rule out structural causes with a renal ultrasound, followed by a renal biopsy for definitive tissue diagnosis. Once acute cellular rejection is confirmed, first-line therapy with high-dose intravenous methylprednisolone is administered. The patient is then monitored for clinical response; if the rejection proves to be steroid-refractory, second-line therapy with a lymphocyte-depleting agent like anti-thymocyte globulin is initiated.

The optimal management of acute renal allograft dysfunction follows a logical progression from non-invasive triage to definitive diagnosis and stepwise treatment. An ultrasound with Doppler is always the first step to quickly exclude reversible surgical or vascular complications. A biopsy is then necessary to determine the exact immunopathologic mechanism. Once acute cellular rejection is diagnosed, high-dose corticosteroids are the standard first-line therapy. Subsequent monitoring dictates whether escalation to potent lymphocyte-depleting agents like anti-thymocyte globulin is necessary for steroid-refractory disease.

Step-by-Step Solution

Exclude structural or vascular causes

Renal allograft ultrasound with Doppler is performed.

Vascular thrombosis, urinary obstruction, or perigraft fluid collections can present identically to rejection and must be ruled out non-invasively first.

Obtain definitive histologic diagnosis

Percutaneous renal allograft biopsy is performed.

Tissue diagnosis is required to differentiate acute cellular rejection from antibody-mediated rejection, polyomavirus (BK) nephropathy, and medication toxicity.

Initiate first-line immunosuppressive therapy

High-dose intravenous methylprednisolone is administered.

Pulse corticosteroids represent the standard initial treatment for acute cellular rejection.

Evaluate response to initial targeted therapy

Graft function is monitored.

A subset of patients will have severe or steroid-resistant rejection, requiring close follow-up of serum creatinine.

Escalate therapy for refractory cases

Anti-thymocyte globulin is administered.

Steroid-refractory rejection necessitates potent T-cell depleting agents as salvage therapy.

Key Concept

The standard approach to acute renal transplant dysfunction involves sequential exclusion of post-surgical and vascular complications, definitive tissue diagnosis via biopsy, and stepwise immunomodulatory therapy starting with pulse steroids and escalating to lymphocyte-depleting agents for refractory cases.

Question 1504Question →

An ambulatory clinic evaluates a retired mail carrier reporting a three-month history of tightness and aching in the right calf. The discomfort reliably begins after walking approximately two blocks and fully resolves after five minutes of standing idle. Comorbidities include diet-controlled type 2 diabetes mellitus, hyperlipidemia, and long-standing tobacco use. Bilateral lower extremity pulses are palpable but faintly diminished on the right. Which of the following physical examination findings would most specifically confirm the suspected etiology of this patient's symptoms?

Sharp exacerbation of the calf discomfort when the examiner abruptly and passively dorsiflexes the affected ankle

Reproduction of the cramping pain when the patient actively extends the lumbar spine while standing

Pronounced indentation of the pretibial skin that persists after applying firm pressure for several seconds

Development of striking foot pallor upon limb elevation followed by intense erythema when placed in a dependent position

A prominent, palpable, and expansile pulsation located deep within the popliteal fossa

Show answer & explanation

Answer: Development of striking foot pallor upon limb elevation followed by intense erythema when placed in a dependent position

Answer

Development of striking foot pallor upon limb elevation followed by intense erythema when placed in a dependent position

The patient's presentation of reproducible, exercise-induced calf pain relieved by standing is highly characteristic of intermittent claudication due to peripheral arterial disease (PAD). The physical examination finding of elevation pallor and dependent rubor (Buerger's test) strongly supports this diagnosis. It indicates severe arterial insufficiency where the arterioles maximally dilate due to chronic tissue ischemia, subsequently causing a striking red or purplish discoloration (rubor) when gravity assists blood flow back into the dependent foot.

Step-by-Step Solution

Analyze the patient's clinical presentation and medical history.

A patient with multiple vascular risk factors (diabetes, hyperlipidemia, smoking) presents with reproducible exertional calf pain that is relieved by rest.

Identifying the classic triad of intermittent claudication (exertional onset, reproducible distance, relief with standing) helps establish peripheral arterial disease (PAD) as the leading diagnosis.

Correlate the suspected diagnosis with specific physical examination maneuvers.

PAD is characterized by signs of poor arterial perfusion, such as diminished pulses, hair loss, and gravity-dependent skin color changes.

Physical examination acts as a critical bedside diagnostic tool to differentiate arterial, venous, and neurologic causes of lower extremity pain.

Evaluate the options to identify the finding that specifically indicates arterial insufficiency.

Elevation pallor followed by dependent rubor (Buerger's test) is the classic specific physical exam sign of PAD.

In PAD, arterioles maximally dilate due to chronic ischemia, causing striking redness (rubor) when gravity assists blood flow into the dependent foot.

Key Concept

Physical Examination Findings of Peripheral Arterial Disease

Question 1505Question →

A 24-year-old man comes to the clinic for a routine physical examination required for a new job. He reports feeling well and has no current complaints. However, he mentions that he occasionally notices a mild yellowish tint to his eyes, particularly when he is stressed or fasting for religious holidays. He takes no medications and does not consume alcohol. Vital signs are temperature 37.0°C (98.6°F), blood pressure 118/76 mmHg, pulse 72/min, and respirations 14/min. Physical examination is notable for mild scleral icterus but no abdominal tenderness or hepatosplenomegaly.

Laboratory results are as follows:

Laboratory Test	Result	Reference Range
Hemoglobin	15.2 g/dL	13.5-17.5 g/dL
Platelet count	250,000/mm³	150,000-400,000/mm³
Reticulocyte count	1.2%	0.5-1.5%
Total bilirubin	2.8 mg/dL	0.1-1.2 mg/dL
Direct bilirubin	0.4 mg/dL	0.0-0.3 mg/dL
Aspartate aminotransferase (AST)	18 U/L	8-20 U/L
Alanine aminotransferase (ALT)	20 U/L	8-20 U/L
Alkaline phosphatase	70 U/L	44-147 U/L

A peripheral blood smear shows normal red blood cell morphology.

Based on these laboratory findings, which of the following is the most likely diagnosis?

Gilbert syndrome

Autoimmune hemolytic anemia

Acute viral hepatitis

Choledocholithiasis

Primary sclerosing cholangitis

Show answer & explanation

Answer: Gilbert syndrome

Answer

The most likely diagnosis is Gilbert syndrome.

The correct answer is Gilbert syndrome. This patient presents with isolated, mild unconjugated hyperbilirubinemia (total bilirubin is elevated, but direct bilirubin is within normal limits, making the indirect fraction elevated). All other liver biochemistries (AST, ALT, alkaline phosphatase) and markers of hemolysis (hemoglobin, reticulocyte count, peripheral smear) are strictly normal. This specific laboratory pattern, particularly when exacerbations are temporally associated with stress or fasting in an otherwise asymptomatic individual, is the hallmark of Gilbert syndrome. It is a benign, inherited deficiency in hepatic UDP-glucuronosyltransferase activity that requires reassurance and no further intervention.

Step-by-Step Solution

Calculate the indirect (unconjugated) bilirubin fraction.

Indirect bilirubin is

2.8 - 0.4 = 2.4 \text{ mg/dL}

, indicating a predominantly unconjugated hyperbilirubinemia.

Determining whether the hyperbilirubinemia is conjugated or unconjugated narrows the differential diagnosis significantly.

Evaluate for signs of hemolysis.

Hemoglobin, reticulocyte count, and peripheral blood smear are all within normal limits.

Hemolysis is a major cause of isolated unconjugated hyperbilirubinemia and must be actively ruled out.

Assess hepatocellular and cholestatic markers.

AST, ALT, and alkaline phosphatase are completely normal.

Normal transaminases and alkaline phosphatase rule out intrinsic liver disease and biliary obstruction, pointing toward a benign isolated bilirubin metabolism disorder.

Key Concept

Interpretation of isolated unconjugated hyperbilirubinemia in an asymptomatic patient

Question 1506Question →

For each of the following patients presenting with clinical and biochemical evidence of hepatic injury, select the most appropriate confirmatory or highly specific diagnostic laboratory evaluation.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Each patient's unique demographic profile, symptom cluster, and initial hepatic panel pattern dictates a highly specific targeted laboratory evaluation: copper studies for Wilson disease, AMA for primary biliary cholangitis, bile acids for intrahepatic cholestasis of pregnancy, iron studies for hemochromatosis, and ASMA/anti-LKM1 for autoimmune hepatitis.

Each clinical scenario provides cardinal demographic features, extrahepatic manifestations, and initial biochemical patterns (hepatocellular vs. cholestatic) that narrow the differential diagnosis to a single leading etiology. Selecting the precise targeted laboratory test prevents unnecessary invasive procedures, limits diagnostic cost, and expedites definitive management.

Step-by-Step Solution

Analyze the 34-year-old man's presentation.

Identify that early-onset neuropsychiatric symptoms paired with transaminitis suggest copper deposition in the basal ganglia and liver, indicating Wilson disease.

Requires targeted testing with serum ceruloplasmin and 24-hour urinary copper.

Evaluate the 51-year-old woman's isolated alkaline phosphatase elevation.

Recognize the classic demographic (middle-aged female) and cholestatic laboratory pattern without ductal dilation as primary biliary cholangitis.

Dictates ordering an antimitochondrial antibody (AMA) titer for confirmation.

Assess the pregnant patient's palmar/plantar pruritus.

Diagnose likely intrahepatic cholestasis of pregnancy given the trimester, symptom location, and normal GGT.

Requires establishing the diagnosis biochemically via fasting serum total bile acid concentration.

Correlate the 45-year-old man's diabetes and MCP arthropathy.

Identify this specific symptom cluster alongside liver inflammation as highly suspicious for iron overload (hereditary hemochromatosis).

Necessitates screening with serum transferrin saturation and ferritin levels.

Synthesize the 38-year-old woman's marked hepatocellular injury and hypergammaglobulinemia.

Recognize the autoimmune diathesis (hypothyroidism) and >500 U/L transaminases as indicative of autoimmune hepatitis.

Prompts ordering anti-smooth muscle antibody and anti-LKM1 assays.

Key Concept

Targeted Diagnostic Laboratory Sequencing for Hepatic Pathology

Estimated Time:2m 0s

Question 1507Question →

A 54-year-old man with a mechanical mitral valve replacement is maintained on a stable daily dose of warfarin. His international normalized ratio (INR) has been consistently in the therapeutic range of $2.5$ to $3.5$ for the past six months. He presents to the urgent care clinic with a 2-day history of purulent drainage from a leg wound and is prescribed a 7-day course of oral trimethoprim-sulfamethoxazole. Four days later, he comes to the emergency department reporting recurrent epistaxis and large ecchymoses on his trunk. Laboratory evaluation reveals an INR of $7.2$ . Which of the following is the most significant pharmacokinetic mechanism responsible for this patient's current laboratory findings?

Eradication of normal intestinal flora leading to reduced endogenous vitamin K synthesis

Displacement of the anticoagulant from its binding sites on plasma albumin

Inhibition of the cytochrome P450-mediated metabolism of the more potent enantiomer

Inhibition of the renal tubular secretion of the unchanged anticoagulant

Down-regulation of the vitamin K epoxide reductase complex in the liver

Show answer & explanation

Answer: Inhibition of the cytochrome P450-mediated metabolism of the more potent enantiomer

Answer

Inhibition of the cytochrome P450-mediated metabolism of the more potent enantiomer

The correct mechanism is the inhibition of the cytochrome P450-mediated metabolism of the more potent enantiomer. Warfarin is a racemic mixture, and its S-enantiomer provides the majority of the anticoagulant effect. Because S-warfarin is exclusively metabolized by the hepatic enzyme CYP2C9, any drug that inhibits this enzyme will drastically reduce warfarin clearance. Trimethoprim-sulfamethoxazole is a potent CYP2C9 inhibitor. Its addition to the patient's regimen blocked the metabolism of S-warfarin, leading to drug accumulation, an exaggerated anticoagulant effect, and clinical bleeding.

Step-by-Step Solution

Analyze the patient's clinical presentation and timeline.

The patient developed a severely elevated INR and bleeding diathesis four days after starting trimethoprim-sulfamethoxazole while on a stable dose of warfarin.

Establishing the precise timeline confirms an acute drug-drug interaction rather than a gradual underlying disease process.

Identify the pharmacokinetic properties of the affected drug (warfarin).

Warfarin is administered as a racemic mixture. The S-enantiomer is roughly three to five times more potent than the R-enantiomer and is predominantly metabolized by hepatic CYP2C9.

Understanding the specific enzymatic pathway of the active drug component is necessary to predict and verify interaction mechanisms.

Determine the exact effect of trimethoprim-sulfamethoxazole on this pathway.

Trimethoprim-sulfamethoxazole potently inhibits the CYP2C9 enzyme, which leads to decreased clearance and subsequent toxic accumulation of S-warfarin.

Matching the offending drug's inhibitory properties with the metabolic pathway of the victim drug isolates the definitive pharmacokinetic mechanism.

Key Concept

Pharmacokinetic drug-drug interactions involving cytochrome P450 2C9 inhibition

Question 1508Question →

A 46-year-old woman comes to the oncology clinic to discuss treatment planning. She recently underwent a lumpectomy and sentinel lymph node biopsy for a right-sided breast mass. Surgical pathology confirmed invasive ductal carcinoma. Immunohistochemical staining demonstrates that the tumor is estrogen receptor-negative, progesterone receptor-negative, and strongly positive ( $3+$ ) for a specific transmembrane receptor tyrosine kinase (HER2/neu). The patient is scheduled to begin an adjuvant chemotherapy regimen that includes a targeted monoclonal antibody against this receptor. The targeted receptor pathway is a primary driver of neoplastic proliferation in her tumor, but it is also physiologically essential for cellular survival and stress response in another major organ system. Based on the mechanism of action of the planned targeted therapy, which of the following baseline diagnostic studies is most critical to obtain prior to treatment initiation?

Echocardiography to evaluate left ventricular ejection fraction

Pulmonary function testing including carbon monoxide diffusion capacity

High-resolution computed tomography of the chest

Measurement of serum thiopurine methyltransferase activity

Baseline audiometry and thorough vestibular assessment

Show answer & explanation

Answer: Echocardiography to evaluate left ventricular ejection fraction

Answer

Echocardiography to evaluate left ventricular ejection fraction is required to assess baseline cardiac function.

The patient's tumor is driven by HER2 overexpression, necessitating treatment with an anti-HER2 monoclonal antibody such as trastuzumab. Because HER2 signaling (often via HER2/HER4 heterodimerization) is physiologically critical for the maintenance and repair of cardiac myocytes under stress, inhibiting this pathway frequently leads to left ventricular contractile dysfunction. Therefore, a baseline evaluation of the left ventricular ejection fraction via echocardiography or radionuclide ventriculography is strictly required before initiating therapy to prevent the exacerbation of underlying heart failure.

Step-by-Step Solution

Identify the molecular driver of the patient's neoplasm.

The tumor overexpresses HER2/neu, a receptor tyrosine kinase that promotes aggressive cell proliferation.

Tumor receptor status dictates the selection of targeted pharmacotherapy.

Determine the indicated pharmacologic intervention.

The patient will receive a HER2-targeted monoclonal antibody, such as trastuzumab.

Targeted therapies significantly improve survival in HER2-amplified malignancies.

Recall the physiologic role of the target receptor in healthy tissues.

In normal physiology, HER2 (pairing with HER4) is essential for the survival, repair, and stress-response of cardiac myocytes.

Understanding the foundational science of the receptor explains the mechanism of drug toxicity.

Select the appropriate clinical management step to prevent adverse events.

An echocardiogram or MUGA scan must be ordered to establish a baseline left ventricular ejection fraction (LVEF).

Because trastuzumab disrupts cardiac myocyte survival pathways, it can cause reversible dilated cardiomyopathy, necessitating strict cardiac monitoring.

Key Concept

Monoclonal antibodies targeting HER2/neu (e.g., trastuzumab) disrupt a signaling pathway that is not only oncogenic in breast tissue but also physiologically vital for cardiac myocyte survival, necessitating baseline and ongoing evaluation of left ventricular ejection fraction.

Question 1509Question →

An infectious disease physician is evaluating a 31-year-old male who reports one week of high fevers, drenching night sweats, and a painfully swollen lump on the right side of his neck. Six weeks prior, the patient was diagnosed with advanced HIV infection (CD4+ cell count: 45/mm³) along with disseminated Mycobacterium avium complex (MAC). At that time, a targeted antimicrobial regimen of azithromycin and ethambutol was initiated. Antiretroviral therapy (ART) was subsequently added four weeks ago. The patient initially showed significant clinical improvement, but his symptoms recurred over the past week. Laboratory studies today reveal a CD4+ cell count of 210/mm³ and an undetectable HIV viral load. Fine-needle aspiration of the enlarged right cervical lymph node yields sterile necrotic material, and acid-fast bacilli staining is negative. Which of the following is the most likely underlying immunologic mechanism for this patient's current presentation?

Pathogen-specific expansion of CD4+ T lymphocytes with exaggerated localized cytokine release

Clonal expansion of drug-resistant microbial strains due to subtherapeutic antimicrobial concentrations

Deposition of drug-associated immune complexes leading to classical complement pathway activation

Inhibition of hepatic cytochrome P450 enzymes causing toxic accumulation of macrolide antibiotics

Antigen-crosslinking of IgE on mast cells due to a newly acquired medication hypersensitivity

Show answer & explanation

Answer: Pathogen-specific expansion of CD4+ T lymphocytes with exaggerated localized cytokine release

Answer

Pathogen-specific expansion of CD4+ T lymphocytes with exaggerated localized cytokine release

The patient is experiencing Immune Reconstitution Inflammatory Syndrome (IRIS). This condition occurs when the initiation of highly active antiretroviral therapy (ART) leads to a rapid restoration of immune function. The newly competent immune system, specifically the rapidly expanding population of pathogen-specific memory CD4+ T cells, mounts an exuberant inflammatory response against residual antigens from previously treated or latent opportunistic infections, such as Mycobacterium avium complex (MAC). This localized cytokine storm causes paradoxical worsening of clinical symptoms, such as necrotic lymphadenitis, even while the actual infectious burden is decreasing.

Step-by-Step Solution

Analyze the patient's clinical timeline and laboratory parameters.

The patient started ART, experienced a robust increase in CD4+ count (from 45 to 210/mm³), and achieved viral suppression, indicating rapid immune recovery.

Identifying rapid immune recovery is the first step in differentiating a paradoxical inflammatory response from an opportunistic infection or treatment failure.

Evaluate the current symptoms in the context of previous diagnoses.

The patient developed a worsening necrotic lymph node (associated with his known MAC infection) despite a sterile aspirate, ruling out uncontrolled active infection.

A sterile, localized inflammatory reaction at the site of a previously treated opportunistic infection strongly points toward an immune-mediated phenomenon.

Synthesize the findings to determine the precise immunologic mechanism.

The clinical picture perfectly matches Immune Reconstitution Inflammatory Syndrome (IRIS), driven by recovering CD4+ T cells mounting an intense response against residual MAC antigens.

Understanding the cellular basis of IRIS is required to select the option describing antigen-specific CD4+ T cell expansion and cytokine release.

Key Concept

Immune Reconstitution Inflammatory Syndrome (IRIS)

Question 1510Question →

A $32$ -year-old woman comes to the primary care clinic reporting a $6$ -month history of chronic diarrhea, abdominal bloating, and an unintentional weight loss of $5$ kg ( $11$ lbs). She describes her bowel movements as bulky, foul-smelling, and difficult to flush. Her medical history is significant for type $1$ diabetes mellitus, which is managed with an insulin pump. Vital signs are within normal limits. Physical examination reveals a mildly distended abdomen with hyperactive bowel sounds but no tenderness, guarding, or organomegaly. Initial laboratory studies show a hemoglobin of $10.5$ g/dL with a mean corpuscular volume of $74$ fL. Which of the following is the most appropriate next step in diagnostic evaluation?

Serum tissue transglutaminase (tTG) IgA antibody and total IgA levels

Computed tomography (CT) of the abdomen and pelvis with intravenous contrast

HLA-DQ2 and HLA-DQ8 genetic testing

Fecal elastase-1 concentration

Quantitative

72

-hour fecal fat measurement

Show answer & explanation

Answer: Serum tissue transglutaminase (tTG) IgA antibody and total IgA levels

Answer

Serum tissue transglutaminase (tTG) IgA antibody and total IgA levels

The correct answer is to order tissue transglutaminase (tTG) IgA antibody and total serum IgA levels. The patient's presentation of chronic diarrhea, steatorrhea (indicated by bulky, foul-smelling stools that are difficult to flush), unintentional weight loss, and microcytic anemia strongly suggests a malabsorptive process. Given her history of type 1 diabetes mellitus, she is at exceptionally high risk for other autoimmune conditions, particularly celiac disease. The most appropriate, cost-effective, and highly sensitive initial laboratory evaluation for celiac disease is testing for tissue transglutaminase (tTG) IgA antibodies. Because selective IgA deficiency is more common in patients with celiac disease (occurring in about 2-3% of these patients) and can lead to false-negative tTG IgA results, a total serum IgA level must be measured simultaneously to validate the serologic screening.

Step-by-Step Solution

Analyze the patient's clinical presentation and laboratory findings.

The patient exhibits chronic diarrhea, steatorrhea, weight loss, and microcytic anemia, which are classic signs of malabsorption. Her history of type 1 diabetes strongly increases the risk for other autoimmune disorders.

Establishing a syndromic diagnosis of malabsorption with an autoimmune predisposition narrows the differential diagnosis significantly toward celiac disease.

Determine the most appropriate initial screening test for the suspected etiology.

The preferred initial test is tissue transglutaminase (tTG) IgA antibody combined with a total serum IgA level.

tTG-IgA is highly sensitive and specific. Total IgA must be measured concurrently because selective IgA deficiency is common in celiac patients and would cause a false-negative tTG-IgA result.

Key Concept

The initial laboratory evaluation for suspected celiac disease includes tissue transglutaminase (tTG) IgA antibody testing accompanied by a total serum IgA level to prevent false-negative results in patients with concurrent selective IgA deficiency.

Estimated Time:1m 0s

Question 1511Question →

A 38-year-old woman is evaluated in the outpatient clinic for progressively worsening fatigue, decreased exercise tolerance, and a persistent craving to chew on ice. She mentions that her menstrual periods have been exceptionally heavy over the last six months, often requiring her to change pads every two hours. Her vital signs are stable and within normal limits.

Initial laboratory testing reveals the following results:

Test	Result	Reference Range
Hemoglobin	8.8 g/dL	12.0 - 15.5 g/dL
Mean corpuscular volume (MCV)	74 fL	80 - 100 fL
Serum ferritin	9 ng/mL	15 - 200 ng/mL
Serum iron	35 $\mu$ g/dL	60 - 170 $\mu$ g/dL
Total iron-binding capacity (TIBC)	480 $\mu$ g/dL	240 - 450 $\mu$ g/dL

Based on the provided laboratory panel, which of the following is the most accurate interpretation of this patient's hematologic status?

Depleted iron stores secondary to chronic blood loss

Iron sequestration secondary to a chronic inflammatory state

Quantitative defect in globin chain synthesis

Defective incorporation of iron into the heme molecule

Impaired red blood cell DNA synthesis

Show answer & explanation

Answer: Depleted iron stores secondary to chronic blood loss

Answer

Depleted iron stores secondary to chronic blood loss

The correct answer accurately identifies the diagnosis as absolute iron deficiency. The patient's laboratory results show a microcytic anemia (MCV < 80 fL). The most critical test for distinguishing causes of microcytosis is serum ferritin, which reflects total body iron stores. A low ferritin level (typically < 15 ng/mL) is highly specific for iron deficiency. Furthermore, in absolute iron deficiency, the liver produces more transferrin in an attempt to maximize iron transport, leading to an elevated Total Iron-Binding Capacity (TIBC). The combination of low ferritin, low serum iron, and high TIBC perfectly aligns with depleted iron stores, which in this patient's case is secondary to chronic blood loss from heavy menstrual bleeding.

Step-by-Step Solution

Analyze the complete blood count (CBC) results.

Hemoglobin is low (8.8 g/dL) indicating anemia, and MCV is low (74 fL) indicating the anemia is microcytic.

Classifying the anemia by red blood cell size is the standard first step in determining the underlying etiology.

Interpret the iron studies panel.

The patient has low serum ferritin (9 ng/mL), low serum iron (35

\mu

g/dL), and an elevated TIBC (480

\mu

g/dL).

Iron studies differentiate the causes of microcytic anemia. A low ferritin is the most specific marker for absolute iron deficiency.

Correlate the laboratory findings with the clinical history.

The combination of microcytic anemia, low ferritin, high TIBC, pica (ice craving), and a history of heavy menses confirms absolute iron deficiency due to chronic blood loss.

Integrating lab data with patient history ensures accurate diagnostic interpretation and excludes other causes of microcytosis.

Key Concept

Iron deficiency anemia is characterized by a microcytic anemia with low serum ferritin, low serum iron, and an elevated total iron-binding capacity (TIBC).

Question 1512Question →

A 71-year-old woman with a 50-pack-year smoking history is referred to the oncology clinic after a routine chest radiograph reveals a 3.2-cm spiculated mass in the right upper lobe and a widened right paratracheal stripe. She has a chronic cough but is otherwise asymptomatic. Her performance status is excellent. Arrange the following steps in the most appropriate, evidence-based sequence for the diagnostic workup, clinical staging, and treatment planning of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the evaluation and management of suspected non-small cell lung cancer is: CT chest for anatomical characterization, followed by a PET scan for metabolic staging, then EBUS-TBNA for tissue diagnosis and pathological nodal staging, followed by multidisciplinary review to determine surgical candidacy, and finally the initiation of stage-directed therapy.

The correct sequence for the evaluation and management of suspected non-small cell lung cancer ensures accurate staging while minimizing unnecessary procedures. Anatomical imaging (CT) characterizes the initial finding. Metabolic imaging (PET) provides whole-body clinical staging and guides the subsequent biopsy. Invasive tissue sampling (EBUS-TBNA) pathologically confirms the diagnosis and precise nodal status. A multidisciplinary tumor board then synthesizes this data to recommend the optimal stage-directed therapy, which is subsequently executed.

Step-by-Step Solution

Identify the need for advanced anatomical imaging.

Contrast-enhanced CT of the chest is selected to characterize the radiographic abnormality.

Plain radiographs lack the resolution to accurately determine the characteristics and local invasion of lung masses, making CT the requisite next step.

Determine the appropriate modality for whole-body clinical staging.

18F-FDG PET scan is utilized to assess for occult metastases and nodal avidity.

Before invasive biopsies, a PET scan maps out the most metabolically active sites to target for tissue sampling and ensures the patient does not have distant metastases.

Select the optimal method for obtaining a tissue diagnosis and confirming nodal stage.

EBUS-TBNA is performed to sample the primary tumor and suspicious paratracheal lymph nodes.

Tissue confirmation is mandatory because PET avidity alone cannot definitively diagnose malignancy or nodal involvement due to potential false positives from infection or inflammation.

Synthesize the gathered clinical and pathological data.

The case is reviewed at a multidisciplinary tumor board.

Complex oncologic decisions require input from medical oncology, radiation oncology, thoracic surgery, and pathology to formulate an optimal, consensus-driven treatment plan.

Execute the formulated treatment plan.

Stage-directed therapy is initiated.

Definitive management relies on accurate prior staging to ensure the intervention provides the best chance of survival and local control.

Key Concept

The diagnostic algorithm for suspected lung cancer systematically progresses from noninvasive anatomical imaging (CT), to metabolic clinical staging (PET), to targeted invasive tissue sampling (EBUS-TBNA), ensuring accurate pathological staging prior to definitive multidisciplinary treatment decisions.

Question 1513Question →

A 34-year-old man with a history of intravenous substance use is brought to the emergency department due to a 1-week history of severe chills, intermittent high fevers, and profound fatigue. His temperature is 39.1°C (102.4°F), blood pressure is 112/64 mm Hg, and pulse is 115/min. Cardiac auscultation reveals a prominent holosystolic murmur heard best at the left lower sternal border that significantly increases in intensity during inspiration. Based on the most likely underlying diagnosis, which of the following physical examination findings may also be characteristic of this patient's condition? (Select all that apply)

Select all that apply

Tender, violaceous subcutaneous nodules on the pads of the fingers and toes

Nontender, erythematous or hemorrhagic macular lesions on the palms and soles

Erythematous, non-pruritic, ring-like skin lesions with central clearing on the trunk

Firm, painless subcutaneous nodules positioned over the extensor surfaces of joints

A sharply demarcated, erythematous facial eruption that characteristically spares the nasolabial folds

Show answer & explanation

Answer: Tender, violaceous subcutaneous nodules on the pads of the fingers and toes; Nontender, erythematous or hemorrhagic macular lesions on the palms and soles

Answer

The correct findings are tender, violaceous subcutaneous nodules on the pads of the fingers and toes (Osler nodes) and nontender, erythematous or hemorrhagic macular lesions on the palms and soles (Janeway lesions).

Infective endocarditis frequently presents with distinct peripheral microvascular phenomena. Tender, violaceous nodules on the digits describe Osler nodes (an immunologic phenomenon), and nontender macular lesions on the palms and soles describe Janeway lesions (septic microemboli). Both are classic, highly tested physical examination findings indicative of infective endocarditis.

Step-by-Step Solution

Analyze the clinical presentation and auscultatory findings.

The patient has a history of intravenous drug use, high fever, and a holosystolic murmur at the left lower sternal border that increases with inspiration (Carvallo's sign).

This triad is highly suspicious for right-sided (tricuspid valve) infective endocarditis, most commonly due to Staphylococcus aureus in this demographic.

Identify the specific physical examination signs associated with the suspected diagnosis.

Classic peripheral stigmata of infective endocarditis include Osler nodes (tender), Janeway lesions (nontender), splinter hemorrhages, and Roth spots.

Recognizing these specific vascular and immunologic phenomena is crucial for supporting the clinical diagnosis of infective endocarditis during the physical examination.

Key Concept

Recognizing the classic peripheral stigmata of infective endocarditis during a physical examination.

Question 1514Question →

A 62-year-old woman presents to the clinic for a routine health maintenance examination. She feels well and reports no bone pain, abdominal pain, or urinary symptoms. Her medical history is unremarkable, and she takes no medications. Vital signs are within normal limits.

A comprehensive metabolic panel and subsequent testing reveal the following laboratory results:

Test	Result	Reference Range
Calcium, total	11.2 mg/dL	8.4-10.2 mg/dL
Phosphorus	2.1 mg/dL	2.7-4.5 mg/dL
Albumin	4.0 g/dL	3.5-5.0 g/dL
Creatinine	0.8 mg/dL	0.6-1.1 mg/dL
Intact parathyroid hormone	105 pg/mL	10-65 pg/mL

Which of the following is the most likely diagnosis?

Primary hyperparathyroidism

Secondary hyperparathyroidism

Humoral hypercalcemia of malignancy

Vitamin D toxicity

Pseudohypercalcemia

Show answer & explanation

Answer: Primary hyperparathyroidism

Answer

Primary hyperparathyroidism is the correct diagnosis.

The correct answer accurately synthesizes the laboratory data. Primary hyperparathyroidism is characterized by autonomous overproduction of PTH. This excess PTH acts on the bones (increasing calcium and phosphorus release) and the kidneys (increasing calcium reabsorption and phosphorus excretion). This directly results in the classic laboratory pattern seen here: hypercalcemia, hypophosphatemia, and an elevated intact PTH.

Step-by-Step Solution

Analyze the serum calcium and albumin levels.

Total calcium is elevated at 11.2 mg/dL. Since albumin is normal at 4.0 g/dL, this represents true hypercalcemia.

Total calcium must always be interpreted in the context of serum albumin to rule out pseudohypercalcemia.

Evaluate the intact parathyroid hormone (PTH) level in the setting of hypercalcemia.

Intact PTH is elevated at 105 pg/mL.

An elevated PTH in the presence of hypercalcemia indicates that the hypercalcemia is PTH-dependent, as a normal parathyroid gland would suppress PTH secretion in response to high calcium.

Synthesize findings to confirm the diagnosis.

Hypercalcemia, hypophosphatemia, and an inappropriately high intact PTH point to autonomous PTH secretion.

These combined findings are the hallmark of primary hyperparathyroidism, most commonly caused by a solitary parathyroid adenoma.

Key Concept

The classic laboratory profile of primary hyperparathyroidism is hypercalcemia, hypophosphatemia, and an elevated or inappropriately normal intact parathyroid hormone (PTH) level.

Question 1515Question →

A 45-year-old man presents to the outpatient clinic for follow-up after his third episode of nephrolithiasis in the past two years. Stone analysis from his most recent episode revealed a pure calcium oxalate composition. He has a history of primary hypertension and obesity. His current medications include amlodipine and various over-the-counter health supplements. He reports drinking 2 to 3 liters of water daily. Which of the following historical elements are MOST important to elicit to identify the underlying risk factors for his recurrent calcium oxalate nephrolithiasis? (Select all that apply)

Select all that apply

History of bariatric surgery or malabsorptive bowel disease

Daily use of high-dose ascorbic acid supplements

High intake of dietary calcium

History of recurrent urinary tract infections

Family history of cystinuria

Show answer & explanation

Answer: History of bariatric surgery or malabsorptive bowel disease; Daily use of high-dose ascorbic acid supplements

Answer

The correct historical elements to elicit are a history of bariatric surgery or malabsorptive bowel disease, and the daily use of high-dose ascorbic acid supplements.

In a patient with recurrent calcium oxalate nephrolithiasis, it is essential to elicit a history of malabsorption (such as from Crohn's disease or Roux-en-Y gastric bypass), which leads to enteric hyperoxaluria. Normally, calcium binds to oxalate in the gut, preventing its absorption. In malabsorptive states, unabsorbed fatty acids bind intraluminal calcium, leaving oxalate free to be absorbed into the bloodstream and excreted in the urine, where it can precipitate as stones. Additionally, high-dose ascorbic acid (vitamin C) supplementation is a critical historical element to evaluate because vitamin C is directly metabolized to oxalate, significantly increasing urinary oxalate excretion and the risk of stone formation.

Step-by-Step Solution

Identify the primary clinical problem and objective.

The patient has recurrent pure calcium oxalate nephrolithiasis and the goal is to identify his specific risk factors through history taking.

Targeting the specific stone composition is necessary to narrow down the differential diagnosis for nephrolithiasis risk factors.

Recall the pathophysiological mechanisms that lead to calcium oxalate stone formation.

Key mechanisms include hypercalciuria, hyperoxaluria, and hypocitraturia.

Understanding the mechanisms allows the clinician to correlate them with potential historical exposures or underlying conditions.

Correlate hyperoxaluria with its common medical and dietary precipitants.

Malabsorptive states (like Roux-en-Y gastric bypass or Crohn's disease) lead to enteric hyperoxaluria. Excessive intake of vitamin C (ascorbic acid) also increases oxalate excretion because vitamin C is metabolized directly into oxalate.

Identifying these triggers guides the precise questions that must be asked during the clinical interview.

Exclude incorrect historical risk factors commonly confused with calcium oxalate pathogenesis.

High dietary calcium is protective, not a risk factor. UTIs cause struvite stones. Cystinuria causes cystine stones.

Recognizing distractors prevents cognitive errors such as misinterpreting stone composition or applying incorrect preventive principles.

Key Concept

Evaluating historical risk factors for calcium oxalate nephrolithiasis involves inquiring about conditions causing enteric hyperoxaluria (e.g., malabsorption, bariatric surgery) and the use of supplements that are metabolized to oxalate (e.g., high-dose vitamin C).

Question 1516Question →

A 42-year-old woman is evaluated in the intensive care unit for new-onset oozing of blood from her intravenous catheter sites and a widespread petechial rash. She was admitted two days ago for severe sepsis secondary to acute pyelonephritis. Her temperature is 38.8°C (101.8°F), blood pressure is 90/55 mmHg, and pulse is 118/min.

Laboratory studies show:

Test	Result	Reference Range
Hemoglobin	8.4 g/dL	12.0-15.5 g/dL
Platelet count	35,000/mm³	150,000-400,000/mm³
Leukocyte count	18,500/mm³	4,500-11,000/mm³
Prothrombin time (PT)	24 seconds	11-15 seconds
Partial thromboplastin time (PTT)	58 seconds	25-40 seconds
Fibrinogen	85 mg/dL	200-400 mg/dL
D-dimer	8,400 ng/mL	< 500 ng/mL

Peripheral blood smear reveals numerous schistocytes.

Based on the laboratory findings, which of the following is the most likely diagnosis?

Disseminated intravascular coagulation

Thrombotic thrombocytopenic purpura

Immune thrombocytopenia

Vitamin K deficiency

Heparin-induced thrombocytopenia

Show answer & explanation

Answer: Disseminated intravascular coagulation

Answer

Disseminated intravascular coagulation

The correct diagnosis is disseminated intravascular coagulation (DIC). DIC is characterized by widespread, systemic activation of the coagulation cascade, leading to the formation of microthrombi throughout the microvasculature. This massive coagulation effort consumes platelets and clotting factors, resulting in thrombocytopenia, prolonged prothrombin time (PT), prolonged partial thromboplastin time (PTT), and low fibrinogen. Simultaneously, the fibrinolytic system is activated to break down these clots, leading to highly elevated levels of fibrin degradation products, such as D-dimer. As red blood cells are forced through small vessels partially occluded by fibrin strands, they are sheared, producing schistocytes (fragmented red blood cells) on the peripheral smear. Severe sepsis is one of the most common triggers for DIC.

Step-by-Step Solution

Analyze the hematologic profile and peripheral smear.

The patient has severe thrombocytopenia and schistocytes.

This combination indicates a microangiopathic hemolytic anemia (MAHA), where red blood cells are sheared by microthrombi in small vessels.

Evaluate the coagulation panel (PT, PTT, fibrinogen, D-dimer).

The PT and PTT are markedly prolonged, fibrinogen is critically low, and D-dimer is significantly elevated.

These findings point to systemic activation of the coagulation cascade with subsequent consumption of coagulation factors and active fibrinolysis.

Synthesize the laboratory data with the clinical presentation.

A consumptive coagulopathy alongside MAHA in a patient with a known trigger (severe sepsis) confirms the diagnosis.

Only disseminated intravascular coagulation perfectly explains the simultaneous consumption of platelets and clotting factors leading to both bleeding (oozing) and thrombosis.

Key Concept

The diagnosis of disseminated intravascular coagulation requires identifying both a consumptive coagulopathy (prolonged PT/PTT, low fibrinogen, elevated D-dimer) and a microangiopathic hemolytic anemia (thrombocytopenia, schistocytes).

Question 1517Question →

Match each clinical and biochemical profile of a patient presenting with a disorder of sex development or steroidogenesis to its precise underlying enzymatic or molecular mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Profile L1 matches 21-hydroxylase deficiency; Profile L2 matches 17-alpha-hydroxylase deficiency; Profile L3 matches androgen receptor mutation; Profile L4 matches 5-alpha-reductase type 2 deficiency.

Each profile perfectly aligns with the biochemical consequences of specific enzymatic or receptor defects in the endocrine pathways governing steroid hormone synthesis and action.

Step-by-Step Solution

Evaluate the first profile (46,XX with salt-wasting and virilization).

Identified as classic congenital adrenal hyperplasia.

Elevated 17-hydroxyprogesterone indicates a block at 21-hydroxylase, leading to absent mineralocorticoids and excess androgens.

Evaluate the second profile (46,XX with hypertension, hypokalemia, and delayed puberty).

Identified as 17-alpha-hydroxylase deficiency.

The block prevents sex hormone synthesis (delayed puberty) and shunts precursors to mineralocorticoids like deoxycorticosterone (hypertension, hypokalemia).

Evaluate the third profile (46,XY with female phenotype, absent uterus, normal male testosterone).

Identified as complete androgen insensitivity syndrome.

Target tissues do not respond to testosterone due to a mutated receptor. The testes produce anti-Müllerian hormone, leading to regression of Müllerian structures (no uterus).

Evaluate the fourth profile (46,XY with ambiguous genitalia and high T/DHT ratio).

Identified as 5-alpha-reductase type 2 deficiency.

The high testosterone-to-dihydrotestosterone ratio specifically points to the inability to convert testosterone to the more potent dihydrotestosterone required for male external genitalia development.

Key Concept

Steroidogenesis pathways and disorders of sex development (DSD)

Question 1518Question →

Emergency medical services bring a 52-year-old man to the emergency department after he was found unresponsive in a park. He has a known history of severe alcohol use disorder. On physical examination, his temperature is $36.5^\circ\text{C}$ ( $97.7^\circ\text{F}$ ), blood pressure is $110/70 \text{ mmHg}$ , pulse is $98/\text{min}$ , and respiratory rate is $16/\text{min}$ . He is uncooperative and confused but moves all extremities spontaneously.

Initial laboratory studies reveal the following:

Laboratory Test	Result	Reference Range
Sodium ( $Na^+$ )	$140 \text{ mEq/L}$	$136 - 145 \text{ mEq/L}$
Potassium ( $K^+$ )	$4.2 \text{ mEq/L}$	$3.5 - 5.0 \text{ mEq/L}$
Chloride ( $Cl^-$ )	$102 \text{ mEq/L}$	$95 - 105 \text{ mEq/L}$
Bicarbonate ( $HCO_3^-$ )	$20 \text{ mEq/L}$	$22 - 28 \text{ mEq/L}$
Blood urea nitrogen (BUN)	$28 \text{ mg/dL}$	$7 - 18 \text{ mg/dL}$
Glucose	$180 \text{ mg/dL}$	$70 - 110 \text{ mg/dL}$
Creatinine	$1.2 \text{ mg/dL}$	$0.6 - 1.2 \text{ mg/dL}$

A toxicology screen is negative for acetaminophen and salicylates. His blood ethanol level is undetectable. The laboratory reports a measured serum osmolality of $324 \text{ mOsm/kg H}_2\text{O}$ .

Based on the provided laboratory results, what is the patient's calculated osmolar gap?

Show answer & explanation

Answer: 24

Answer

The patient's osmolar gap is exactly

24

. Calculated serum osmolality is found using the formula:

2 \times [\text{Na}^+] + \frac{[\text{BUN}]}{2.8} + \frac{[\text{Glucose}]}{18}

. Substituting the provided lab values yields:

2(140) + \frac{28}{2.8} + \frac{180}{18} = 280 + 10 + 10 = 300 \text{ mOsm/kg H}_2\text{O}

. The osmolar gap is the measured osmolality (

324 \text{ mOsm/kg H}_2\text{O}

) minus the calculated osmolality (

300 \text{ mOsm/kg H}_2\text{O}

), which equals

24

. An elevated gap (normal is

\leq 10

) in the context of an uncooperative, confused patient with an alcohol use disorder strongly suggests toxic alcohol ingestion, such as methanol or ethylene glycol, requiring further diagnostic workup and potential treatment with fomepizole.

Step-by-Step Solution

Calculate the expected serum osmolality using the formula:

2 \times \text{Na}^+ + \frac{\text{BUN}}{2.8} + \frac{\text{Glucose}}{18}

Calculated osmolality =

2(140) + \frac{28}{2.8} + \frac{180}{18} = 280 + 10 + 10 = 300 \text{ mOsm/kg H}_2\text{O}

This formula estimates the total concentration of the major osmotically active solutes in the plasma under normal physiological conditions.

Calculate the osmolar gap by subtracting the calculated serum osmolality from the measured serum osmolality.

Osmolar gap =

324 - 300 = 24

The osmolar gap quantifies the presence of unmeasured osmotically active substances (such as toxic alcohols) in the patient's blood.

Key Concept

The osmolar gap is determined by subtracting the calculated serum osmolality from the laboratory-measured serum osmolality. A normal gap is typically

\leq 10 \text{ mOsm/kg H}_2\text{O}

; an elevated gap suggests the presence of unmeasured exogenous osmoles.

Estimated Time:1m 0s

Question 1519Question →

A 48-year-old woman is evaluated in the outpatient clinic for persistently elevated blood pressure. She was diagnosed with hypertension six months ago. Her blood pressure today is $168/98 \text{ mmHg}$ despite verified adherence to maximum tolerated doses of amlodipine and valsartan. The patient reports occasional headaches and generalized weakness over the past two months but otherwise feels well. Her past medical history is notable for osteoarthritis and generalized anxiety disorder. Her current medications include amlodipine, valsartan, and acetaminophen as needed. She explicitly denies using nonsteroidal anti-inflammatory drugs. She does not smoke or consume alcohol. BMI is $24 \text{ kg/m}^2$ . Physical examination reveals a regular heart rate of $78 \text{ /min}$ and no abdominal bruits, edema, or focal neurologic deficits.

Laboratory studies show:
Serum sodium: $144 \text{ mEq/L}$
Serum potassium: $2.8 \text{ mEq/L}$
Serum chloride: $102 \text{ mEq/L}$
Serum bicarbonate: $30 \text{ mEq/L}$
Serum creatinine: $0.8 \text{ mg/dL}$
Plasma renin activity: Undetectable
Plasma aldosterone concentration: $< 2 \text{ ng/dL}$

Which of the following questions is most appropriate to ask next to determine the underlying etiology of this patient's condition?

Do you regularly consume traditional black licorice or herbal supplements for digestion?

Do you often wake up gasping for air or feel excessively sleepy during the day?

Are you taking any herbal supplements containing St. John's wort for your anxiety?

Have you experienced any episodes of palpitations accompanied by a throbbing headache and sweating?

Is there a family history of early-onset kidney disease or renal artery interventions?

Show answer & explanation

Answer: Do you regularly consume traditional black licorice or herbal supplements for digestion?

Answer

The most appropriate next step is to ask the patient about the consumption of traditional black licorice or herbal supplements containing licorice root.

The correct answer addresses the dietary and supplement history specifically linked to apparent mineralocorticoid excess (AME). This patient presents with resistant hypertension, marked hypokalemia, and metabolic alkalosis. Crucially, her endocrine workup reveals that both plasma renin activity and plasma aldosterone concentration are suppressed. This profile rules out primary hyperaldosteronism (Conn syndrome) and secondary causes of hyperaldosteronism (like renal artery stenosis). Instead, it points to a substance activating the mineralocorticoid receptors independently of aldosterone. Glycyrrhizin, an active compound found in traditional black licorice and various herbal preparations, inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11-beta-HSD2) in the renal collecting duct. This enzyme normally converts active cortisol into inactive cortisone. When it is inhibited, high local levels of cortisol bind to and activate mineralocorticoid receptors. This mimics the action of aldosterone, leading to sodium retention (causing hypertension) and potassium/hydrogen excretion (causing hypokalemia and metabolic alkalosis). The resulting volume expansion suppresses endogenous renin and aldosterone. Therefore, eliciting a history of licorice or specific supplement ingestion is the critical diagnostic step.

Step-by-Step Solution

Identify the primary clinical problem from the vignette.

The patient has resistant hypertension complicated by significant hypokalemia and metabolic alkalosis.

Recognizing the triad of hypertension, hypokalemia, and metabolic alkalosis narrows the differential diagnosis to mineralocorticoid excess states.

Interpret the specific endocrine laboratory data.

Both plasma renin activity and plasma aldosterone concentration are profoundly suppressed.

This specific profile rules out primary hyperaldosteronism (where aldosterone would be high and renin low) and secondary hyperaldosteronism (where both would be high).

Formulate a differential diagnosis for hypertension with hypokalemia and low renin/low aldosterone.

The findings indicate a state of Apparent Mineralocorticoid Excess (AME). In an adult without a lifelong history of hypertension, this is almost exclusively an acquired condition.

Acquired AME is caused by an exogenous substance that acts on the mineralocorticoid receptor or prevents cortisol degradation.

Connect the pathophysiology to the medical history evaluation.

Glycyrrhizin, found in traditional black licorice and some herbal supplements (often used for dyspepsia), inhibits the enzyme responsible for cortisol degradation in the kidneys.

Asking about licorice or specific herbal supplement ingestion directly targets the underlying etiology of her acquired AME.

Key Concept

Evaluating the history for exogenous causes of apparent mineralocorticoid excess (e.g., licorice ingestion) when labs show hypertension, hypokalemia, low renin, and low aldosterone.

Question 1520Question →

A 64-year-old man with a history of advanced non-small cell lung cancer presents to the emergency department reporting two days of worsening shortness of breath, profound generalized weakness, and episodes of near-syncope. He states he feels slightly more comfortable when sitting upright and leaning forward. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 86/66 mmHg, heart rate of 124/min and regular, and respiratory rate of 26/min. The patient appears diaphoretic, and his extremities are cool and clammy. Examination of the neck reveals marked distension of the jugular veins up to the angle of the mandible while the patient is sitting at a 45-degree incline. Based on the most likely underlying pathophysiological process causing this patient's acute decompensation, which of the following additional physical examination findings are most likely to be present? (Select all that apply.)

Select all that apply

An inspiratory drop in systolic blood pressure of 18 mmHg

Distant and difficult-to-auscultate heart sounds

An absent or severely blunted 'y' descent on the jugular venous pressure waveform

A paradoxical increase in jugular venous pressure during inspiration

A high-pitched, early diastolic extra heart sound heard best at the left lower sternal border

Show answer & explanation

Answer: An inspiratory drop in systolic blood pressure of 18 mmHg; Distant and difficult-to-auscultate heart sounds; An absent or severely blunted 'y' descent on the jugular venous pressure waveform

Answer

The correct findings are an inspiratory drop in systolic blood pressure of 18 mmHg (pulsus paradoxus), distant and difficult-to-auscultate heart sounds, and an absent or severely blunted 'y' descent on the jugular venous pressure waveform.

Cardiac tamponade represents a form of obstructive shock caused by the accumulation of fluid in the pericardial space under high pressure. This pressure compresses all cardiac chambers, leading to impaired diastolic filling and severely reduced cardiac output. The classic physical examination findings include Beck's triad: hypotension (often with a narrow pulse pressure), jugular venous distension, and muffled or distant heart sounds due to the insulating layer of fluid. Additionally, the external fluid compression exaggerates normal ventricular interdependence during inspiration, leading to pulsus paradoxus (a drop in systolic blood pressure of

>10

mmHg during inspiration). Because the high intrapericardial pressure restricts right ventricular filling primarily in early diastole, the 'y' descent on the jugular venous waveform (which corresponds to rapid right atrial emptying into the right ventricle) is characteristically blunted or absent.

Step-by-Step Solution

Analyze the clinical presentation and vital signs to determine the primary hemodynamic problem.

The patient has a history of lung cancer and presents with acute dyspnea, hypotension (86/66 mmHg) with a narrow pulse pressure, compensatory tachycardia, and prominent jugular venous distension.

Identifying the constellation of obstructive shock (hypotension with elevated central venous pressure) is crucial for narrowing the differential diagnosis.

Formulate the most likely diagnosis based on the clinical context.

The combination of hypotension, prominent jugular venous distension, and an underlying malignancy heavily favors cardiac tamponade (likely secondary to a malignant pericardial effusion).

Malignant pericardial effusion frequently progresses to cardiac tamponade, which classically presents with Beck's triad (hypotension, jugular venous distension, muffled heart sounds).

Deduce the specific physical examination findings associated with the pathophysiology of cardiac tamponade.

Cardiac tamponade is characterized by pulsus paradoxus (an inspiratory drop in systolic blood pressure

>10

mmHg), muffled heart sounds, and a prominent 'x' descent with an absent or blunted 'y' descent on the jugular venous waveform.

These specific signs directly reflect external compression of the heart throughout the cardiac cycle, which exaggerates normal ventricular interdependence and severely restricts early diastolic filling.

Key Concept

Physical examination findings characteristic of Cardiac Tamponade

PreviousPage 76 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept